Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2021 - 10 - 07 save search
Amgen Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK 101 Study In Patients With KRAS G12C-mutated Cancers At AACR-NCI-EORTC 2021
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.77%
H: 4.53%
C: 4.35%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.69%
H: 1.88%
C: 0.28%
phase 1 cancer phase 1b phase 2b
Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.56%
H: 2.18%
C: 1.77%
presentation molecular cancer conference
Prelude Therapeutics Announces Presentation of Encouraging Data from Multiple Programs at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
PRLD | $3.81 10.76% 9.71% 58K
|
Health Technology
|
| O: -14.52%
H: 0.0%
C: -29.51%
presentation molecular cancer conference
Immunotherapeutic Benefits of the DPX Delivery Platform Featured in Two Poster Presentations at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: 0.93%
H: 1.84%
C: -1.84%
presentation molecular cancer liver conference
BridgeBio Pharma Announces First Publication of Preclinical Data for its Potentially Best-in-Class SHP2 Inhibitor Designed for Treatment of Resistant Cancer, Showing Response in Established Non-small Cell Lung Cancer Models
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.2%
H: 3.57%
C: -0.56%
treatment lung cancer potential cancer preclinical pre-clinical designation
Pan-Cancer Analysis Suggests Fibroblast Activation Protein (FAP) is an Attractive Target for Peptide-Targeted Radionuclide Therapy with FAP-2286
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 2.08%
H: 2.04%
C: -0.23%
therapy cancer
LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
LVTX | $2.72 -3.89% -4.04% 130K
|
|
| O: -3.3%
H: 5.92%
C: 0.77%
treatment molecular cancer conference t-cell
Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.14%
H: 5.79%
C: 5.79%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.21%
H: 0.95%
C: 0.62%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -1.07%
H: 8.36%
C: 4.51%
lung cancer phase 1 cancer
CORRECTING and REPLACING: LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 18:00) - globenewswire.com
LVTX | $2.72 -3.89% -4.04% 130K
|
|
| O: -3.3%
H: 5.92%
C: 0.77%
treatment molecular cancer conference t-cell
Rain Therapeutics Presents Data on Milademetan (RAIN-32) at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 14:15) - globenewswire.com
RAIN | $1.21 0.0% 3.7M
|
Manufacturing
|
| O: -0.54%
H: 2.3%
C: -7.71%
molecular cancer conference
Phio Pharmaceuticals Presents New BRD4 Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 13:15) - investors.phiopharma.com
PHIO | $0.631 -1.07% -1.08% 29K
|
Health Technology
|
| O: 2.81%
H: 0.55%
C: -0.55%
molecular cancer conference
Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
GLUE | $5.84 -1.35% -1.37% 110K
|
Professional, Scientific, and T...
|
| O: 0.1%
H: 3.64%
C: -2.44%
treatment rosa potential molecular cancer preclinical pre-clinical
Ikena Oncology Presents Data at AACR-NCI-EORTC Virtual Conference Demonstrating Potential of TEAD Inhibitors in Cancer Treatment
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
IKNA | $1.3 3.18% 3.08% 330K
|
Manufacturing
|
| O: 0.28%
H: 11.59%
C: 8.9%
treatment potential cancer conference
Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 45.75%
H: 2.13%
C: -5.69%
molecular cancer conference preclinical pre-clinical
Salarius Pharmaceuticals and Nationwide Children’s Hospital Disclose Research Findings from Presentation at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 0.23%
H: 4.9%
C: 2.15%
presentation molecular cancer children research conference
Editas Medicine to Present Preclinical Data on Novel Engineered iPSC Derived NK Cells for the Treatment of Cancer at the Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: 0.99%
H: 5.99%
C: 2.95%
treatment immunotherapy therapy cancer preclinical pre-clinical
Caesars Slots held a temporary "shutdown" to promote early breast cancer detection this National Breast Cancer Awareness Month
Published: 2021-10-07 (Crawled : 12:00) - prnewswire.com
PLTK F | $6.88 0.0% 540K
|
|
| O: 0.8%
H: 1.52%
C: -0.72%
cancer breast cancer
Forma Therapeutics’ FT-7051 is Well-tolerated and Demonstrates Evidence of Activity in Initial Results from Ongoing Phase 1 Courage Study in Men with Metastatic Castration-resistant Prostate Cancer
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
FMTX | $20.01 -0.15%
|
Health Technology
|
| O: -1.06%
H: 0.0%
C: -12.12%
ongoing prostate cancer phase 1 results cancer
Second Genome Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Demonstrating that a Novel Peptide, SG-3-0020, Upregulates Co-stimulatory and Checkpoint Pathways
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.03%
H: 1.21%
C: 0.95%
molecular cancer conference preclinical pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.